Our timelines and innovation are unprecedented. This is our focus, which is why we do it best. Ultimately, we help companies get drugs to patients faster and more cost-effectively.
With the ability to express any recombinant protein, including difficult-to-express proteins, Selexis is proud to have partnered with the following companies, and others, supporting the development of innovative therapies across a range of diseases:
Click below to learn more about partnering and collaborating with Selexis.